← Back to Patent Explorer
US4742004A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for producing enzymatically active eucaryotic sod in bacteria

Assignee: Savient Pharmaceuticals Inc
•
Filing: 1984-08-27
•
Granted: 1988-05-03
•
Expires: 2004-08-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of producing enzymatically active eucaryotic superoxide dismutase or an analog thereof in a bacterial cell which contains and is capable of expressing a DNA sequence encoding the superoxide dismutase or analog thereof comprising maintaining the bacterial cell under suitable conditions and in a suitable production medium. The production medium is supplemented with an amount of Cu++ so that the concentration of Cu++ in the medium is greater than about about 2 ppm. The invention also concerns methods of recovering purified enzymatically active eucaryotic superoxide dismutase or analogs from bacterial cells producing the superoxide dismutase or analog.

Inventors

  • 👤 Jacob R. Hartman
  • 👤 Dov Kanner
  • 👤 Daniel Bartfeld

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 10:00
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0089; A; A23; A23K; A23K20/00; A23K20/10; A23K20/168; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/44; A61K38/446; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/61; C07K14/775; C12N15/00; C12N15/09; C12N15/63; C12N15/67; C12N15/69; C12N15/70; C12N15/73; C12Y; C12Y115/00; C12Y115/01; C12Y115/01001

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 124 words
A method of producing an enzymatically active polypeptide analog of human Cu/Zn superoxide dismutase having the identical amino acid sequence and activity of naturally occurring human Cu/Zn superoxide dismutase which comprises: growing a culture of bacterial cells in a zinc containing production medium supplemented with a nongrowth inhibiting amount of Cu ++ such that the final concentration of Cu ++ in the medium is greater than 2 ppm, wherein said cells contain and are capable of expressing DNA encoding the polypeptide analog of human Cu/Zn superoxide dismutase and wherein said culture is grown under suitable conditions such that the DNA is expressed and the polypeptide is produced in the bacterial cells; and recovering the enzymatically active analog of human Cu/Zn superoxide dismutase so produced.
Claim 2
Independent Claim 124 words
A method of producing an enzymatically active polypeptide analog of human Cu/Zn superoxide dismutase having the identical amino acid sequence and activity of naturally occurring human Cu/Zn superoxide dismutase which comprises: growing a culture of bacterial cells in a zinc containing production medium supplemented with a nongrowth inhibiting amount of Cu ++ such that the final concentration of Cu ++ in the medium is greater than 2 ppm, wherein said cells contain and are capable of expressing DNA encoding the polypeptide analog of human Cu/Zn superoxide dismutase and wherein said culture is grown under suitable conditions such that the DNA is expressed and the polypeptide is produced in the bacterial cells; and recovering the enzymatically active analog of human Cu/Zn superoxide dismutase so produced.
Claim 3
Dependent Claim 15 words
A method as in claim 1, wherein the bacterial cell is an Escherichia coli cell.
Claim 4
Dependent Claim 36 words
A method as in claim 1 wherein said culture of bacterial cells has been transformed with a plasmid, wherein said plasmid contains the DNA sequence encoding said polypeptide analog of human Cu/Zn superoxide dismutase incorporated therein.
Claim 5
Dependent Claim 15 words
A method as in claim 1, wherein said production medium is a casein hydrolysate medium.
Claim 6
Dependent Claim 13 words
A method as in claim 1, wherein said production medium is LB medium.
Claim 7
Dependent Claim 19 words
A method as in claim 1, wherein said Cu ++ concentration is from about 50 to about 250 ppm.
Claim 8
Dependent Claim 15 words
A method as in claim 4, wherein said Cu ++ concentration is about 200 ppm.
Claim 9
Dependent Claim 15 words
A method as in claim 5, wherein said Cu ++ concentration is about 75 ppm.
Claim 10
Dependent Claim 35 words
A method as in claim 1, wherein said production medium is also supplemented with an amount of Zn ++ so that the concentration of Zn ++ in the medium is greater than about 2 ppm.
Claim 11
Dependent Claim 30 words
A method as in claim 9, wherein said production medium is supplemented with about 0.8 g/l CuSO 4 .5H 2 O and about 10 mg/l ZnSO 4 .7H 2 O.
Claim 12
Dependent Claim 24 words
A method as in claim 3, wherein said plasmid is pSODβ 1 , pSODα2, pSODβ 1 T11, pSODβ 1 -BA2 or pSODβ 1 TT-1.
Claim 13
Dependent Claim 20 words
A method as in claim 1, wherein said bacterial cell is Escherichia coli strain A2097 containing plasmid pSODα2 ATCC 39786.
Claim 14
Dependent Claim 115 words
A method of recovering purified enzymatically active human Cu/Zn superoxide dismutase analog of claim 1 which comprises: (a) isolating the bacterial cells from the production medium; (b) disrupting the bacterial cells so as to form a suspension comprising cell debris and a protein supernatant solution; (c) separating said cell debris from the soluble protein supernatant solution; (d) heating said separated protein supernatant at about 65° C. for about 2 hours; (e) cooling the heated protein supernatant; (f) separating the resulting protein supernatant so as to produce a clear supernatant protein solution containing the superoxide dismutase thereof analog thereof; and (g) recovering the enzymatically active human Cu/Zn superoxide dismutase analog from the clear supernatant protein solution.
Claim 15
Dependent Claim 66 words
The method of claim 13, wherein the recovery of the enzymatically active human Cu/Zn superoxide dismutase analog from the clear supernatant protein solution further comprises: (a) treating the clear supernatant protein solution to obtain a concentrated solution of the superoxide dismutase analog; (b) subjecting the concentrated solution to both anion and cation exchange chromatography; and (c) collecting the resulting fractions containing purified superoxide dismutase analog thereof.
Claim 16
Independent Claim 128 words
A method of producing an enzymatically active polypeptide analog of human Cu/Zn superoxide dismutase having the identical amino acid sequence and activity of naturally occurring human Cu/Zn superoxide dismutase which comprises: growing a culture of cells of a strain of E. coli in a zinc containing production medium supplemented with an amount of Cu ++ such that the final concentration of Cu ++ in the medium is greater than 2 ppm wherein said cells contain a plasmid capable of expressing DNA encoding a polypeptide analog of human Cu/Zn superoxide dismutase, and wherein said plasmid is selected from the group consisting of pSODβ 1 T 11 , pSODβ 1 , pSODβ 1 TT-1 and pSODβ 1 -BA2; and recovering said polypeptide analog from the E. coli cells so cultured.
Claim 17
Independent Claim 128 words
A method of producing an enzymatically active polypeptide analog of human Cu/Zn superoxide dismutase having the identical amino acid sequence and activity of naturally occurring human Cu/Zn superoxide dismutase which comprises: growing a culture of cells of a strain of E. coli in a zinc containing production medium supplemented with an amount of Cu ++ such that the final concentration of Cu ++ in the medium is greater than 2 ppm wherein said cells contain a plasmid capable of expressing DNA encoding a polypeptide analog of human Cu/Zn superoxide dismutase, and wherein said plasmid is selected from the group consisting of pSODβ 1 T 11 , pSODβ 1 , pSODβ 1 TT-1 and pSODβ 1 -BA2; and recovering said polypeptide analog from the E. coli cells so cultured.

References Cited (Backward Citations)

US3579495A Cited
US4340675A Cited
US4390628A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-05-03 1991-11-02 1992-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-05-03 1995-11-02 1996-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-05-03 1999-11-02 2000-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag